COVID death rate was 3X lower in those with Multiple Sclerosis (85 pcnt were taking Vitamin D) - Jan 2022

---

Characteristics of COVID-19 in patients with multiple sclerosis - Jan 2022

Multiple Sclerosis and Related Disorders 57 (2022) 103437 - Authors from Iran https://doi.org/10.1016/j.msard.2021.103437

Study obeserved, but did not comment on the fact that
   85% of MSers were taking Vitamin D

Background: Regarding the high prevalence of multiple sclerosis (MS) and COVID-19 in Iran, a multicenter study
Multiple rclercste of COVID-19 in Iranian MS patients with is carried out to address the concerns of this population.
COVID-l9

Methods: Data on MS patients with COVID-19 from nine provinces of Iran were entered in a web-based registry system, between July 2020 and March 2021. Among the COVID-19 symptoms, dyspnea, altered mental status, or those resulting in hospital admission were considered severe.

Results: A total of 397 eligible patients were identified. In addition, 310 (78%) were female. The mean age was 36.5 ± 9.5. 294 (74%) patients had relapsing- remitting form. Also, four patients (1%) expired due to COVID-19 infection. The mean duration of admission in hospitalized patients was 9 (± 5.3) days. MRI was performed on 111 (28%) patients after developing COVID-19. MRI changes were observed in 27 (24%) of these cases. MS drug was changed in 26 (6%) patients. Steroid use in the past three months (OR: 2.43, 95% CI: 1.003-5.88) (p value: 0.049) and antiCD20s (OR: 4.03, 95% CI: 2.41-6.68) (p value < 0.001) showed significant association with severe COVID-19 symptoms.

Conclusion: The death rate of COVID-19 among MS patients (1%) is lower than the overall death rate of the pandemic in Iran (3%). Those who received steroid in the past three months may be at increased risk of more severe forms of COVID-19. There are still doubts about the effect of anti CD20s on COVID-19 severity.
 Download the PDF from VitaminDWiki

---

VitaminDWiki - Multiple Sclerosis patients had fewer COVID-19 problems (Note: many MSers take Vitamin D) – April 30, 2021

---

VitaminDWiki - MS updates from Brazil

• Treatment with daily high doses of vitamin D Overcoming MS May 2013
  Of course, this is not a cure it's a life-long treatment.. but at least it stops the progression and in many cases even revert back some (sometimes all) of the brain lesions.
• Huge page - all in Portuguese about Coimbra's work
• Web site of patients who have been cured by Dr. Coimbra Australia 150 ng is the target
  Great sequential posts, over a year. by an Australian patient whose MS was reversed by Dr. Coimbra
• I Have Multiple Sclerosis: I Am Treating My MS With High Doses Vitamin D experienceproject. May 2013
  Gives a fair amount of details, such as taking lots of water and monitoriing for excess Calcium.
  Note A home test kit for excess Calcium in the urine is available $10 for 10 tests
• Dr. Holick visited with the patients in Brazil Sept 2013

---

VitaminDWiki - Multiple Sclerosis 32 percent less likely among those with more than 32 ng of vitamin D – Dec 2019 contains

• Overview MS and vitamin D
• An opportunity - use Vitamin D to treat Multiple Sclerosis (has been used for 14 years) - Feb 2022
• Multiple Sclerosis treated when use high doses of vitamin D – meta-analysis May 2018
• Multiple Sclerosis: 10 percent fewer relapses for each 10 ng higher level of vitamin D – Meta-analysis April 2020
• Multiple Sclerosis: number needed to treat with vitamin D may be as low as 1.3 – Meta-analysis Oct 2013
• Multiple Sclerosis more likely if poor vitamin D genes - 22nd study – Aug 2017
• Multiple Sclerosis relapses cut in half by 100,000 IU of Vitamin D every 2 weeks– RCT 2019

UV and Sunshine reduces MS risk

• Multiple Sclerosis 2X more likely if low winter UV – June 2018
• Multiple Sclerosis half as likely if get plenty of sunshine (not a news item) – March 2018

Other things also help

• Multiple Sclerosis treated by 50,000 IU Vitamin D bi-weekly plus Omega-3 – RCT July 2018
• Multiple Sclerosis 40 percent less likely if consume tinned fish (Vitamin D and Omega-3) – Sept 2019
• Resveratrol treats Multiple Sclerosis and other autoimmune diseases – many studies
• Not a single case of multiple sclerosis in 15,000,000 people (plant-based diets)

High Dose Vitamin D and cofactors

• Coimbra protocol using high-dose Vitamin D is safe – April 2022
• The use of high dose Vitamin D (Coimbra Protocol) for multiple sclerosis in Germany – 2019
• Comparing High-dose vitamin D therapies MS and other health problems

Number of MS studies which are also in other categories

• 22 studies in Genetics - genes can restrict Vitamin D getting to the blood and to the cells
• 12 studies in Vitamin D Receptor - gene which restricts D from getting to the cells
• 7 studies in Vitamin D Binding Protein - gene which restricts D from getting to the cells
• 21 studies in Ultraviolet light - may be even better than Vitamin D in preventing and treating MS
• 9 studies in Omega-3 - which helps Vitamin D prevent and treat MS